Assyro AI

FDA Orange Book · active-ingredient family

Pasireotide diaspartate

Pasireotide diaspartate is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:SIGNIFOR · NDA 200677

1

Brand (NDA)

0

Generics (ANDA)

1

Listed patents

0

Exclusivity periods

Brand (NDA) products · solution

ProductApplicantApplicationTEApproved
SIGNIFORRLD×3RECORDATI RARENDA 200677—Dec 14, 2012

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7473761Dec 14, 2026in 6 mo
SubstanceProduct

Pasireotide diaspartate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo